Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative StudyNeuroethics · 2026-08-01In-silico toxicity study of tryptamine, psilocin, psilocybin, N,N-dimethyltryptamine, 5’-methoxy-N,N-dimethyltryptamine and O-acetylpsilocinArchives of Toxicology · 2026-08-01Psychedelic Use and Missed Needed Mental Health Treatment: Gender Differences in Unmet Perceived Need for CarePsychoactives · 2026-05-11From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-10Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study ProtocolPsychoactives · 2026-04-13Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action.Pharmacology research & perspectives · 2026-04-01Journeying into Right Relations: Scientists Turn to Psilocybin to Shift Psychological Burdens of Global Environmental Change and Find Transformational Pathways ForwardAction Research · 2026-03-01An open-label pilot study of psilocybin-assisted therapy for binge eating disorder.Journal of eating disorders · 2026-01-03Additional file 1 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2026-01-01Additional file 2 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2026-01-01A Comparative Neurophenomenology of the Psychedelic State and Autism: Predictive Processing as a Unifying LensPsychoactives · 2025-11-14Classic psychedelics may treat depressive disorders, but more evidence and legislative changes are requiredDrugs & Therapy Perspectives · 2025-11-04Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted TherapyPsychoactives · 2025-11-02Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathwayNaunyn-Schmiedeberg's Archives of Pharmacology · 2025-10-01The Legal Perspective on Psilocybin for Medical Use in Czechia: A Key Milestone and the Case for Broader Consideration Beyond the Clinical SettingPsychoactives · 2025-09-11Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia CarePsychoactives · 2025-09-02Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case ReportPsychoactives · 2025-09-01Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?European archives of psychiatry and clinical neuroscience · 2025-08-01Psilocybin Use in an Intercollegiate Athlete with Persisting Symptoms After Concussion: A Case ReportPsychoactives · 2025-07-01Increasing the Evaluation and Reporting Rigor of Psychotherapy Interventions in Treatments Involving PsychedelicsPsychoactives · 2025-06-29Regulatory Challenges of Integrating Psychedelics into Mental Health SectorPsychoactives · 2025-04-22Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine PathwaysPharmacology Research & Perspectives · 2025-04-01From Efficacy to Effectiveness: Evaluating Psychedelic Randomized Controlled Trials for Trustworthy Evidence-Based Policy and Practice.Pharmacology research & perspectives · 2025-04-01Elucidating the Phase I metabolism of psilocin in vitroArchives of Toxicology · 2025-03-01Psychedelics for Moral Bioenhancement in Healthy Individuals-A Violation of the Non-Maleficence Principle?Psychoactives · 2025-02-06Funding Success of United States Federal Grant Applications Proposing to Study Therapeutic Applications of Psychedelics: A Survey StudyPsychoactives · 2025-02-05Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent MannerMolecules · 2024-10-28Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine-A Systematic Review and Meta-AnalysisPsychoactives · 2024-10-03B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult PopulationsArchives of Clinical Neuropsychology · 2024-09-12Minorities’ Diminished Psychedelic Returns: Gender, Perceived Stigma, and DistressPsychoactives · 2024-06-02Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney's lesions.European archives of psychiatry and clinical neuroscience · 2024-06-01Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for DepressionPsychoactives · 2024-04-15The Effects of Psilocybin on Lipopolysaccharide-Induced Inflammation in THP-1 Human MacrophagesPsychoactives · 2024-01-28Introduction to the Special Section on Psychedelics Research and TreatmentPerspectives in biology and medicine · 2024-01-01Valuing the Acute Subjective Experience.Perspectives in biology and medicine · 2024-01-01Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment.Perspectives in biology and medicine · 2023-01-01A-118 Psychedelic Interventions for Neuropsychological ConditionsArchives of Clinical Neuropsychology · 2022-08-16Psilocybin: A brief overview for psychiatric mental health nurse practitioners.Perspectives in psychiatric care · 2022-07-01Case Report: Magic Mushroom (Psilocybe Cubensis) IntoxicationArchives of The Medicine and Case Reports · 2021-10-13Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.Archives of general psychiatry · 2011-01-01Hallucinogenic drug-induced behavior under sensory attenuation. Prediction of response to psilocybin.Archives of general psychiatry · 1973-03-01Dynamics of Psychedelic Drug AbuseArchives of General Psychiatry · 1967-05-01